共 50 条
- [1] Efficacy of teclistamab in patients (pts) with heavily pretreated, relapsed/refractory multiple myeloma (RRMM), including those refractory to penta RRMM and BCMA (B-cell maturation antigen) directed therapy (BDT)JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Venkatesh, Priyanka论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS USAAtrash, Shebli论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS USAPaul, Barry论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS USAAlkharabsheh, Omar论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS USAAfrough, Aimaz论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS USAMahmoudjafari, Zahra论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS USAMushtaq, Muhammad Umair论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS USAHashmi, Hamza论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS USADavis, James A.论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS USAAbdallah, Al-Ola A.论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Med Ctr, Kansas City, KS USA
- [2] Pooled Analysis of MagnetisMM Studies: Efficacy and Safety of Elranatamab in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Previously Exposed to B-cell Maturation Antigen (BCMA)-Directed TherapiesAMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S27 - S28Ajay, Nooka K.论文数: 0 引用数: 0 h-index: 0机构: Winship Canc Inst, Atlanta, GA USA Winship Canc Inst, Atlanta, GA USAAlexander, Lesokhin M.论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Div Hematol Oncol, New York, NY USA Winship Canc Inst, Atlanta, GA USAMahamad, Mohty论文数: 0 引用数: 0 h-index: 0机构: Sorbonne Univ, Hop St Antoine, Paris, France INSERM, UMRs938, Paris, France Winship Canc Inst, Atlanta, GA USARuben, Niesvizky论文数: 0 引用数: 0 h-index: 0机构: New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA Winship Canc Inst, Atlanta, GA USAChristopher, Maisel论文数: 0 引用数: 0 h-index: 0机构: Baylor Univ, Med Ctr, Dallas, TX USA Winship Canc Inst, Atlanta, GA USABertrand, Arnulf论文数: 0 引用数: 0 h-index: 0机构: Hop St Louis, Paris, France Winship Canc Inst, Atlanta, GA USASarah, Larson M.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Med Ctr, Los Angeles, CA USA Winship Canc Inst, Atlanta, GA USANina, Asya Varshavsky-Yanovsky论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA USA Winship Canc Inst, Atlanta, GA USAXavier, Leleu论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Poitiers, Poitiers, France Winship Canc Inst, Atlanta, GA USALionel, Karlin论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Lyon, Lyon, France Winship Canc Inst, Atlanta, GA USADavid, Vesole H.论文数: 0 引用数: 0 h-index: 0机构: Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA Winship Canc Inst, Atlanta, GA USANizar, Bahlis J.论文数: 0 引用数: 0 h-index: 0机构: Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada Winship Canc Inst, Atlanta, GA USAde Larrea Carlos, Fernandez论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Barcelona, Spain Winship Canc Inst, Atlanta, GA USANoopur, Raje论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Winship Canc Inst, Atlanta, GA USAEric, Leip论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Cambridge, MA USA Winship Canc Inst, Atlanta, GA USAUmbarto, Conte论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, New York, NY USA Winship Canc Inst, Atlanta, GA USAMohamed, Elmeliegy论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, San Diego, CA USA Winship Canc Inst, Atlanta, GA USAAndrea, Viqueira论文数: 0 引用数: 0 h-index: 0机构: Pfizer SLU, Madrid, Spain Winship Canc Inst, Atlanta, GA USASaloman, Manier论文数: 0 引用数: 0 h-index: 0机构: Lille Univ Hosp, Lille, France Winship Canc Inst, Atlanta, GA USA
- [3] Infectious Complications of B-Cell Maturation Antigen (BCMA)-Targeted Therapies for Relapsed/Refractory Multiple MyelomaBLOOD, 2022, 140 : 10081 - 10083Hoeynck, Brian论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Dept Med, Philadelphia, PA 19104 USA Univ Penn, Dept Med, Philadelphia, PA 19104 USAHwang, Wei-Ting论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA USA Univ Penn, Dept Med, Philadelphia, PA 19104 USAGarfall, Alfred L.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA Univ Penn, Dept Med, Philadelphia, PA 19104 USASusanibar-Adaniya, Sandra Patricia论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA Univ Penn, Dept Med, Philadelphia, PA 19104 USAVogl, Dan T.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA Univ Penn, Dept Med, Philadelphia, PA 19104 USAWaxman, Adam论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA Univ Penn, Dept Med, Philadelphia, PA 19104 USAStadtmauer, Edward A.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA Univ Penn, Dept Med, Philadelphia, PA 19104 USACohen, Adam D.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Dept Med, Philadelphia, PA 19104 USA
- [4] B-Cell Maturation Antigen (BCMA) as a Target for New Drug Development in Relapsed and/or Refractory Multiple MyelomaINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 24Abramson, Hanley N.论文数: 0 引用数: 0 h-index: 0机构: Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA
- [5] Preferences among patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM) in the era of B-cell maturation antigen (BCMA)-directed T-cell-engaging therapiesJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Ailawadhi, Sikander论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USAInocencio, Timothy J.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USAMansfield, Carol论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USAChintakayala, Phani论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USABussberg, Cooper论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USAChi, Lei论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USAHarnett, James论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USAKroog, Glenn Scott论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USAHouvras, Yariv论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USARodriguez-Lorenc, Karen论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USAMa, Qiufei论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin Florida, Jacksonville, FL USA
- [6] Efficacy and Safety of Elranatamab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) and Prior B-Cell Maturation Antigen (BCMA)-Directed Therapies: Pooled Analysis From MagnetisMM StudiesCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S496 - S497Nooka, Ajay K.论文数: 0 引用数: 0 h-index: 0机构: Winship Canc Inst, Atlanta, GA USA Winship Canc Inst, Atlanta, GA USALesokhin, Alexander M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY USA Winship Canc Inst, Atlanta, GA USAMohty, Mohamad论文数: 0 引用数: 0 h-index: 0机构: Sorbonne Univ, Hop St Antoine, Paris, France INSERM, UMRs938, Paris, France Winship Canc Inst, Atlanta, GA USANiesvizky, Ruben论文数: 0 引用数: 0 h-index: 0机构: New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA Winship Canc Inst, Atlanta, GA USAMaisel, Christopher论文数: 0 引用数: 0 h-index: 0机构: Baylor Univ, Med Ctr, Dallas, TX USA Winship Canc Inst, Atlanta, GA USAArnulf, Bertrand论文数: 0 引用数: 0 h-index: 0机构: Hop St Louis, Paris, France Winship Canc Inst, Atlanta, GA USALarson, Sarah M.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Med Ctr, Los Angeles, CA USA Winship Canc Inst, Atlanta, GA USAVarshavsky-Yanovsky, Asya Nina论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA Winship Canc Inst, Atlanta, GA USALeleu, Xavier论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Poitiers, Poitiers, France Winship Canc Inst, Atlanta, GA USAKarlin, Lionel论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Lyon, Lyon, France Winship Canc Inst, Atlanta, GA USAVesole, David H.论文数: 0 引用数: 0 h-index: 0机构: Hackensack Univ, John Theurer Canc Ctr, Med Ctr, Hackensack, NJ USA Winship Canc Inst, Atlanta, GA USABahlis, Nizar J.论文数: 0 引用数: 0 h-index: 0机构: Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada Winship Canc Inst, Atlanta, GA USAFernandez de Larrea, Carlos论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Barcelona, Spain Winship Canc Inst, Atlanta, GA USARaje, Noopur论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Winship Canc Inst, Atlanta, GA USALeip, Eric论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Cambridge, MA USA Winship Canc Inst, Atlanta, GA USAConte, Umberto论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, New York, NY USA Winship Canc Inst, Atlanta, GA USAElmeliegy, Mohamed论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, San Diego, CA USA Winship Canc Inst, Atlanta, GA USAViqueira, Andrea论文数: 0 引用数: 0 h-index: 0机构: Pfizer SLU, Madrid, Spain Lille Univ Hosp, Lille, France Winship Canc Inst, Atlanta, GA USA
- [7] Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: A pooled analysis from MagnetisMM studies.JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Nooka, Ajay K.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USALesokhin, Alexander M.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAMohty, Mohamad论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USANiesvizky, Ruben论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAMaisel, Christopher论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAArnulf, Bertrand论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USALarson, Sarah Marie论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAYanovsky, Asya Varshavsky论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USALeleu, Xavier P.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAKarlin, Lionel论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAVesole, David H.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USABahlis, Nizar J.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAde Larrea, Carlos Fernandez论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USARaje, Noopur S.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USALeip, Eric论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAConte, Umberto论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAElmeliegy, Mohamed论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAViqueira, Andrea论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USAManier, Salomon论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USA
- [8] Efficacy and safety of elranatamab in pts with relapsed/ refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: a pooled analysis from MagnetisMM studiesONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 232 - 232Raab, M. S.论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, Germany Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyHanel, M.论文数: 0 引用数: 0 h-index: 0机构: Klinikum Chemnitz, Chemnitz, Germany Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyNooka, A. K.论文数: 0 引用数: 0 h-index: 0机构: Winship Canc Inst, Atlanta, GA USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyLesokhin, A. M.论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Coll, Div Hematol & Oncol, Mem Sloan Kettering Canc Ctr, New York, NY USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyMohty, M.论文数: 0 引用数: 0 h-index: 0机构: Sorbonne Univ, Hop St Antoine, Paris, France Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyNiesvizky, R.论文数: 0 引用数: 0 h-index: 0机构: New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyMaisel, C.论文数: 0 引用数: 0 h-index: 0机构: Baylor Univ, Med Ctr, Dallas, TX USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyArnulf, B.论文数: 0 引用数: 0 h-index: 0机构: Hop St Louis, Paris, France Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyLarson, S. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Med Ctr, Los Angeles, CA USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyVarshavsky-Yanovsky, A. N.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyLeleu, X.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Poitiers, Poitiers, France Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyKarlin, L.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Lyon, Lyon, France Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyVesole, D. H.论文数: 0 引用数: 0 h-index: 0机构: Hackensack Univ, John Theurer Canc Ctr, Med Ctr, Hackensack, NJ USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyBahlis, N. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, Germanyde larrea, Fernandez C.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Barcelona, Spain Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyRaje, N.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyLeip, E.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Cambridge, MA USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyConte, U.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, New York, NY USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyElmeliegy, M.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, San Diego, CA USA Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyViqueira, A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer SLU, Madrid, Spain Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, GermanyManier, S.论文数: 0 引用数: 0 h-index: 0机构: Lille Univ Hosp, Lille, France Heidelberg Univ, Dept Hematol Oncol, Heidelberg Myeloma Ctr, Heidelberg, Germany
- [9] Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed TherapyCANCERS, 2023, 15 (11)Atrash, Shebli论文数: 0 引用数: 0 h-index: 0机构: Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC 28204 USA US Myeloma Res Innovat Res Collaborat USMIRC, Westwood, KS 66205 USA Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC 28204 USAMammadzadeh, Aytaj论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol Oncol, Rochester, MN 55905 USA Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC 28204 USAPeng, Fulei论文数: 0 引用数: 0 h-index: 0机构: Mercy St Louis Hosp, Dept Internal Med, Mercy St, St Louis, MO 63141 USA Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC 28204 USAAlkharabsheh, Omar论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Res Innovat Res Collaborat USMIRC, Westwood, KS 66205 USA Univ S Alabama, Div Hematol Oncol, Mitchell Canc Inst, Mobile, AL 36604 USA Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC 28204 USAAfrough, Aimaz论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Res Innovat Res Collaborat USMIRC, Westwood, KS 66205 USA UT Southwestern Med Ctr, Div Hematol Oncol, Dallas, TX 75390 USA Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC 28204 USACui, Wei论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Res Innovat Res Collaborat USMIRC, Westwood, KS 66205 USA Univ Kansas, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC 28204 USAMahmoudjafari, Zahra论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Res Innovat Res Collaborat USMIRC, Westwood, KS 66205 USA Univ Kansas, Div Pharm, Med Ctr, Westwood, KS 66160 USA Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC 28204 USAAbdallah, Al-Ola论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Res Innovat Res Collaborat USMIRC, Westwood, KS 66205 USA Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Med Ctr, Westwood, KS 66160 USA Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC 28204 USAHashmi, Hamza论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Res Innovat Res Collaborat USMIRC, Westwood, KS 66205 USA Med Univ South Carolina, Div Hematol Oncol, Charleston, SC 29425 USA Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC 28204 USA
- [10] Role of B-Cell Maturation Antigen (BCMA) Targeted Immunotherapies in Relapsed and Refractory Multiple Myeloma- a Systematic ReviewBLOOD, 2019, 134Shah, Zunairah论文数: 0 引用数: 0 h-index: 0机构: Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USA Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USABatool, Syeda Sabeeka论文数: 0 引用数: 0 h-index: 0机构: UAB Huntsville Reg Med Campus, Huntsville, AL USA Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAFazeel, Hafiz Muhammad论文数: 0 引用数: 0 h-index: 0机构: Serv Inst Med Sci, Lahore, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAMalik, Mustafa Nadeem论文数: 0 引用数: 0 h-index: 0机构: Univ Arizona, Internal Med, Tucson, AZ USA Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USASadiq, Maryam论文数: 0 引用数: 0 h-index: 0机构: Nister Med Coll, Multan, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAHassan, Syeda Fatima论文数: 0 引用数: 0 h-index: 0机构: Fatima Jinnah Med Univ, Iahore, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USASyed, Tariq Iqtidar Sadiq论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Taussig Canc Ctr, Taussig Ctr, Dept Hematol,Med Oncol, Cleveland, OH 44106 USA Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAAbdullah, Syed Maaz论文数: 0 引用数: 0 h-index: 0机构: King Edward Med Univ, Lahore, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAJaved, Nisma论文数: 0 引用数: 0 h-index: 0机构: Shaukat Khanum Mem Canc Hosp, Lahore, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAAshraf, Aqsa论文数: 0 引用数: 0 h-index: 0机构: King Edward Med Univ, Dept Internal Med, Lahore, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAFarooqui, Arafat Ali Ali论文数: 0 引用数: 0 h-index: 0机构: King Edward Med Univ, Dept Internal Med, Lahore, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAYousaf, Muhammad Abdullah论文数: 0 引用数: 0 h-index: 0机构: Rawalpindi Med Univ, Rawalpindi, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAAhmad, Muhaddis Ejaz论文数: 0 引用数: 0 h-index: 0机构: Rawalpindi Med Univ, Islamabad, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAGhani, Marium论文数: 0 引用数: 0 h-index: 0机构: Dow Med Coll, Karachi, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAAkbar, Arshia论文数: 0 引用数: 0 h-index: 0机构: Rawalpindi Med Univ, Dept Internal Med, Rawalpindi, Pakistan Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USAAnwer, Faiz论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Dept Hematol, Taussig Canc Ctr, Med Oncol, Cleveland, OH USA Cleveland Clin, Dept Hematol, Taussig Canc Ctr, Med Oncol, Cleveland, OH 44106 USA Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USA